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ABSTRACT  
 
Abstract Title: Comparison of HIV seroprevalence between males and females 
at clinic and community level in Mpumalanga South Africa. 
 
Background: Two cross-sectional surveys were conducted in Embalenhle 
community (February 2002) and Dunusa community mobile clinics (November 
2001), to establish prevalence of HIV and STIs (Chlamydia trachomatis and 
Neisseria gonorrhea).   
 
Methods: Multiple logistic regression models were fitted to the combined data 
from the two sites, to identify factors associated with HIV prevalence and also to 
check whether the effects were consistent over the two sites.  
 
Results: HIV Prevalence was 33.5% (30.2%vs.35.9% in males and females 
respectively, p=0.124) at community site and 34.8% at clinic site (22.8%vs.47.4% 
in males and females respectively, p=0.001). The models show a significant site 
by sex interaction i.e. the effect of sex differs in the 2 sites (p=0.036). After 
adjusting for agegroup and Neisseria gonorrhea, predicted probabilities from the 
logistic regression model shows that the  sex difference is much greater in 
community mobile clinics (23%vs.44.1% in males and females respectively) than 
at the community site (29.9%vs.34.9% in males and females respectively). After 
adjusting for site and Neisseria gonorrhea, the model showed an agegroup by 
sex interaction (p<0.001). Predicted probabilities show a difference, where HIV in 
males is higher than in females; in males in the 25-34 year age group from 18-24 
years (36.3 vs 18.2 % respectively), while in females the prevalence is very 
similar in the 18-24 year and 25-34 year age groups. There were no interactions 
between Neisseria gonorrhea and other variables.   
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Conclusions: The different HIV–age distribution for males and females are 
consistent with the results of previous studies. We found that the sex difference 
in prevalence was much smaller at the community level than at the clinic level. 
The traditional interpretation of national antenatal surveillance data assumes a 
fairly large difference in male and female seroprevalence (a ratio of 7:10 is used 
in extrapolating results of the South African National antenatal seroprevalence 
survey to males). These results suggest that more work is needed in checking 
that assumption. 
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1. Introduction 
 
1.1 Statement of the problem and research question 
 
Available data on HIV prevalence in sub-Saharan Africa suggest large 
differentials in male to female HIV seroprevalence in different population settings 
(1). This large differential suggests the need to further explore and quantify this 
gap in order to effect optimal planning in HIV prevention efforts. This study aimed 
to conduct an exploratory analysis of HIV seroprevalence data collected from two 
cross-sectional surveys to investigate the differences in sex-related HIV 
prevalence and the degree of extrapolation of HIV prevalence from females in a 
clinic setting to males in the general population; and also to investigate specific 
risk factors and whether or not these risk factors were consistent over the two 
sites. 
 
1.2 Justification of the study
There has been an increasing need for estimates and projections of HIV 
prevalence in recent years for advocacy purposes, monitoring and evaluating 
trends of incidence, impact of relevant interventions and planning for future 
needs and resource allocations (2).  A major assumption, using HIV serological 
testing, is that HIV prevalence found in antenatal populations can, with 
adjustment for the estimated male to female ratio, be used as a surrogate for HIV 
seroprevalence in the total 15-49 year population (2). This assumption, used in 
sub-Saharan Africa, is supported by limited community based HIV sero-surveys 
which suggest that HIV seroprevalence among antenatal females is a reasonable 
surrogate value for HIV seroprevalence in the general population and for the 
general male population (2). This assumption has not been validated.  
Measurement and/or estimation of the male to female ratio of HIV infections have 
been carried out using a variety of methods and assumptions. As many settings 
do not factor in a male to female ratio in their process of estimating their national 
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HIV seroprevalence, this could result in gross bias if antenatal data are used 
without any adjustment to estimate HIV prevalence in both males and females 
(2). All HIV prevalence estimations should try to ensure that the overall HIV 
prevalence estimated is consistent with the estimated male to female ratio. The 
study aims to explore the large differentials in male to female ratios. 
 
1.3 Background and literature review 
 
The HIV/AIDS epidemic globally is still on the increase. According to the UNAIDS 
2005 global summary of the AIDS epidemic report, approximately 38.6 million 
(33.4 million - 46.0million) people were living with HIV by the end of 2005 (3, 4). 
About 4.1 million new HIV infections (3.4 million – 6.2 million) and an estimated 
2.8 million deaths were recorded in the same year (3). 
 
Overall the HIV incidence rate is believed to have peaked globally, although the 
rate is still increasing in several countries (4) 
 
Globally, 3.8% (3.0%-4.7%, n=54 countries) of young females, aged 15-24 years 
are HIV infected (4). 
 
Approximately 60% (25.8-40.3 million) of all people living with HIV in the world 
live in sub-Saharan Africa despite having just a meagre 10% of the world’s 
population (4). This highlights the magnitude of the HIV/AIDS burden the sub-
Saharan African Region is currently experiencing (4). The region had an 
estimated 3.2 million new infections and 2.4 million deaths due to AIDS in 2005 
(4). Unfortunately, there is no convincing evidence yet of a decline in epidemic 
prevalence rates in southern Africa (4). 
 
The available data on HIV prevalence in sub-Saharan Africa indicate substantial 
heterogeneity in the spread of HIV across the continent. Large differences exist 
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between and within countries and a range of biological, behavioural and 
contextual arguments have been advanced to explain these differences (1, 5).  
 
Biological explanations include those that focus on different sub-types of HIV-1 
and variation in prevalence of other sexually transmitted infections (STIs). Male 
circumcision, inextricably linked with cultural practices, is also considered an 
important biological factor in understanding the differentials in risk of HIV 
transmission and prevention (6, 7). Differences in sexual practice, whether or not 
in relation to the response to the epidemic, have also been considered as 
important explanatory factors, as have differences in underlying factors, such as 
mobility, infrastructure and poverty.  
 
An important attempt to assess factors affecting the differential spread of HIV in 
urban Africa was made in a multi-centre study of four cities (8, 9). Two cities had 
a very high prevalence of HIV in the general population (Kisumu, Kenya and 
Ndola, Zambia) and two cities had much lower prevalence (Yaounde, Cameroon 
and Cotonou, Benin). The study design combined ecological comparisons across 
populations with individual level analysis within populations, and it was concluded 
that differences affecting the efficiency of HIV transmission, notably lack of male 
circumcision and prevalence of ulcerative STIs, including Herpes Simplex Virus-2 
(HSV-2), were the most important explanatory factors, while differences in high 
risk sexual behaviour appeared to play a much smaller role. The main 
differences in the latter pertained to earlier sexual debut, earlier marriage and 
larger age difference between spouses in the high prevalence cities (8).  
 
Boisson et. al. propose a model that  uses HIV prevalence estimated for 
pregnant women from unlinked anonymous surveys to determine the prevalence 
of HIV in women in the same population (10). The model assumes the ratio of 
prevalence in pregnant women to that in all women is influenced by HIV-related 
risk behaviours that are different for pregnant and non-pregnant women and also 
by differences in fertility level among infected and uninfected women. The ratio is 
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affected by biases, likely to be culturally or socially specific, and which are 
qualified and quantified by the model. 
 
Like most countries in the sub-Saharan region, South Africa is also bearing the 
brunt of the HIV/AIDS pandemic with a reported 5.6 million people living with the 
HI virus giving a prevalence rate of 11.4% (11). Of these, 15.6% are adults in the 
economically active age groups, and 15.2% of persons in the 15-49 age group 
were HIV positive. The high prevalence of HIV/AIDS impacts negatively on 
productivity and sustainability of all developmental programs due to significant 
reduction of human resource capacity in all sectors.  
 
A study done by the South African Department of Health involving more than  
16 500 pregnant women attending antenatal services across all the nine 
provinces in 2005 found that 30.2% (95% CI 29.1; 31.2) were HIV positive (12).  
Amongst all the provinces, Kwa-Zulu Natal province recorded the highest HIV 
rate of 39.1% (95% CI 36.8; 41.4) (11). The most recent HIV antenatal survey 
estimated a national sero-prevalence of 29.1% (95% CI 28.3; 29.9) (13). 
Data from ANC surveys for 2002, 2003 and 2004 were analyzed to establish HIV 
prevalence trends that showed an increase of HIV prevalence in HIV positive 
pregnant women from 27.9(95% CI 26.8; 28.9) in 2003 to 30.2% (95% CI 29.1; 
31.2) in 2005 (12). After adjusting for the effect of province and age group, a 
three year increase was statistically significant between the period 2002 and 
2004 (p<0.001) (14). 
 
In many, if not all settings, sentinel surveillance in antenatal clinics (ANC) is the 
chief source of routine HIV prevalence information, but provides no information 
on males (14).  
 
The Human Sciences Research Council (HSRC), in partnership with the Medical 
Research Council (MRC), Centre for AIDS Development, Research and 
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Evaluation (CADRE), and Agencé Nationale de Recherches sur le Sida (ANRS), 
conducted South Africa’s first national household study of HIV/AIDS in 2002 (11). 
The survey included gathering of data on HIV prevalence, behaviour and 
communication. The national community household survey conducted in 2002 
(11), demonstrated an HIV prevalence in males 12.8%, and females 17.7%. 
However the overall response rate (at the level of having an HIV test) was low 
and the results may have been subject to non-response bias. The result of this 
survey found an HIV seroprevalence of 17.7% in females aged 15-49 years old 
and show a quite a large difference to the 2001 Department of Health Antenatal 
survey which found an HIV prevalence of 24.8% in Antenatal Clinic Attendees 
(15).  
 
The 2005 SA National HIV survey was the second household survey conducted 
by the Human Sciences Research Council and sampled nearly twice as many 
study participants as the first (16). The results presented below are similar to 
those of the 2002 HSRC survey, however they are quite different from the SA 
National Department of annual Antenatal Clinic Health Survey of pregnant 
women and also disagree with UNAIDS estimate of 21.5% of South Africans 
aged between 15 -49 years living with HIV at the end of 2003.  
 
 
Figure 1 Distribution of HIV seroprevalence between males and females 
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Figure 1 illustrates the distribution of HIV seroprevalence between males and 
females (HSRC, 2005) with the females having the highest rate in the 15-34 year 
age band. 
 
Table 1. Distribution of HIV seroprevalence among females compared 
between the National Department Antenatal Survey and HSRC Survey 
 
Age group
% (n) 95% CI % (n) 95% CI % (n) 95% CI
15-19 9.5 (1 153) 7.1-12.4 19.7 (79) 10.0-35.2 16.1 (3130) 14.7-17.5
20-24 23.9 (1 182) 19.8-28.4 25.0 (303) 18.0-33.7 30.8 (4991) 29.3-32.3
25-29 33.3 (598) 27.7-39.4 32.1 (184) 21.6-44.7 38.5 (3702) 36.8-40.3
30-34 26.0 (691) 21.5-30.9 20.6 (157) 12.9-31.1 34.4 (2510) 32.2-36.6
35-39 19.3 (727) 14.9-24.6 15.7 (126) 9.4-25.3 24.5 (1 261) 21.9-27.2
40-49 10.7 (1 299) 8.6-13.3 11.3 (69) 4.7-24.8 17.5 (382) 14.0-21.0
Total 20.2 18.3-22.2 23.2 19.0-28.1 29.5 28.5-30.5
Pregnant in the last 24
months n=918
Antenatal Survey 2004
n=15 976
Females 2005 n=5650
 
 
Table 1 compares HIV prevalence among females in the 15–49 year age group 
with findings of the annual antenatal survey conducted by the Department of 
Health in 2004. HIV prevalence in five-year age bands for all females aged 15–
49, and for those who were pregnant in the last 24 months in the 2nd HSRC 
Community Based Survey is provided for comparison (16). The overall HIV 
prevalence in females participating in the 2005 household survey was 20.2% 
(16). In the survey sample of females who were pregnant in the last 24 months  
(n = 918), 23.2% were HIV positive (16). These figures are lower than the 29.5% 
HIV prevalence found in the 2004 antenatal survey (14). However, the household 
survey included females of all race groups, regardless of whether or not they 
were sexually active, whilst the antenatal survey is only representative of 
pregnant females using government clinics. Taking into account a differential 
utilization rate of these clinics by race and income group well over 90% of the 
females in the 2004 antenatal survey were African females (14). 
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 Figure 2 Distribution of HIV seroprevalence by agegroup between females 
in the National Department of Health Survey and HSRC Survey 
 
Figure 2 shows a descriptive comparison of African females from both HSRC 
Community Based Survey (2005) and the National Department of Health ANC 
survey (2004). Although a descriptive comparison, both surveys predict similar 
overall levels of HIV prevalence, and show that the growing epidemic is a cause 
for concern both in the general population and the targeted ANC population (11, 
14).  
 
Data from the first HSRC study however suggests a somewhat different 
provincial prevalence picture (11). Gauteng, Free State and Mpumalanga had the 
highest prevalence rates, while all other provinces had prevalence rates that 
were about or below 10%. KwaZulu Natal ranked fourth and the Eastern Cape 
has the lowest prevalence. The observed prevalence for women aged 15-49 
years old in the Western Cape of 18.5% was much higher than that observed 
from antenatal data. This was the only province, as described in the HSRC 
community based survey, where the HIV prevalence derived from the household 
survey was much higher than that derived from the antenatal data.  
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The traditional interpretation of national antenatal surveillance data assumes a 
fairly large difference in male and female seroprevalence (a ratio of 7:10 is used 
in extrapolating results of the South African National antenatal seroprevalence 
survey to males) (17). 
 
Zaba et. al. (18) propose that data on age of the father be collected in antenatal 
sentinel HIV sero-prevalence surveys to estimate overall and age-specific male 
HIV prevalence; however this method may produce an under-estimate of male 
prevalence, especially in the oldest age groups, because of the fertility reducing 
effects of HIV and the age pattern of discordancy.  Other anticipated drawbacks 
are: 1. reliance on questionable assumptions (e.g. that both partners share the 
same sero-status); 2. exclusion of men who are without regular partners or not 
currently sexually active or infertile or contraceptive users; 3. willingness and 
ability of women to disclose information. 
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1.4 Study Objectives 
 
1.4.1 Aim 
 
To conduct secondary data analysis to look at HIV prevalence across the two 
sites and to examine factors associated with HIV. 
 
1.4.2 Objectives 
 
1. To compare the prevalence of HIV and selected STIs between the two 
sites. 
 
2. To look at the relative risk of HIV infection for females versus males and 
compare this between the two sites. 
 
3. To look for specific risk factors for HIV infection and whether these are 
consistent over the two sites. 
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2. Methodology 
 
2.1 Study design 
 
This study was a secondary analysis and made use of data that was originally 
collected in a cross-sectional study.  
 
2.2 Description of the study population, measurements taken and 
instruments used 
 
The original study commissioned by the Council for Scientific and Industrial 
Research, used a cross sectional study design (19). The aim of this study was to 
determine HIV prevalence in Embalenhle community in November 2001 and 
Dunusa Mobile clinics in February 2002. Embalenhle and Dunusa are coal 
mining towns in Mpumalanga and major labour sending areas.  
The study population comprised of adults (males and females) who were 
included into the study from both community and clinic for Embalenhle and 
Dunusa respectively. All males and females aged 18 years or older who gave 
verbal consent and who agreed to provide a specimen for an unlinked 
anonymous HIV test were included in the study. This study is a secondary 
exploratory analysis. Sites were selected according to the initial study design that 
was conducted by the CSIR (described below). 
 
2.2.1 Description of original sampling for Embalenhle 
For purposes of the cross sectional study considered in this secondary analysis, 
participants from Embalenhle were selected using a two stage household sample 
design. Field workers recruited participants from the community based on a 
representative sample and patients presenting in the community (Embalenhle). 
The rational for site selection was to describe HIV seroprevalence in these 
settings so as to implement HIV interventions in these settings. The sites were 
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selected conveniently in the initial operational study. Embalenhle was mapped 
into 3 sections which served as clusters. HIV testing was unlinked and 
anonymous. Study participants were recruited from sections A, B and C and 
tested at Zone 14 and Zone 4 Clinics in Embalenhle. 
 
2.2.2 Description of original sampling for Dunusa 
Participants in Dunusa mobile clinics were selected using systematic sampling. 
The rational for site selection was to describe HIV seroprevalence in these 
settings so as to implement HIV interventions in these settings. The sites were 
selected conveniently in the initial operational study. Field workers recruited 
participants from the community based on a representative sample and patients 
presenting at clinics (Dunusa). The majority of patients (greater than 90%) at 
Dunusa were clinic attendees. Dunusa mobile clinic and Impungwe Hospital 
participated in the survey. 
 
2.3 Data management, processing and data analysis 
 
2.3.1 Data variables 
 
The study made use of biological markers. In addition, a socio-demographic and 
behavioural questionnaire was administered to participants during study visits.  
 
The variables available for the secondary data analysis are presented below. The 
analysis was constrained to measurements of the variables below and the 
investigator was not allowed to use socio-demographic variables that was also 
captured.  
1. Age 
2. Sex 
3. HIV status 
4. STIs 
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a. Neisseria gonorrhoeae  
b. Chlamydia trachomatis 
5. Site 
a. Dunusa 
b. Embalenhle 
  
CSIR has access to these variables only. The data from the socio-demographic 
questionnaire would have added a deeper insight into investigating the 
relationship between sexes at the two sites. These variables were however not 
available from the service provider due to contractual reasons.  
 
2.3.2 Data cleaning 
 
Some of the problems that the study encountered with the two data sets were: 
 
• Data was captured into a Microsoft excel file and double data entry was 
not performed.   
• Missing values were not appropriately coded  
• The service providers for the original study collected data on participants 
who did not meet the eligibility criteria for the survey. The criteria for 
inclusion included age specific criteria of > 18 years and less than 50 
years for inclusion into the analysis. 
 
2.3.3 Database cleaning  
 
All data cleaning was performed in STATA 8. Frequency checks were performed 
on all variables to determine the extent of missing values in the database and 
missing data was encoded using standard operating procedures. These 
procedures included replacing all missing data with specific numerical values of 
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‘99’ and ’999’ which was subsequently excluded from the basic and multivariate 
analysis. 
 
2.3.4 Data coding  
 
In order to facilitate data analysis, most raw data variables required further 
manipulation and/or grouping resulting in the creation of new database variables. 
Data was exported from MS Excel to STATA 8.0, via StatTransfer 7.0, to 
facilitate higher level coding and manipulation of data. Several secondary 
variables were created to describe further associations between categorical 
variables and HIV status; certain variables were recoded as categorical 
variables, many with only two levels to determine the level of risk exposure. 
Please refer to the analysis section for details on coding of the results. 
 
2.3.5 Data archiving 
 
Each participant has a confidentially-named clinic record, containing details of 
visit date, signed consent and laboratory results. The records were identified by 
a bar-code and unique study number only. Copies are kept at the CSIR 
Miningtek.  
 
Individuals were given an information sheet. The records and logs were kept in 
a secure location at the managing centre, for the duration of the study. 
 
2.3.6 Data ownership 
 
Each case record has a confidentially-named record, containing details of 
interview dates and data collected. It was the responsibility of the investigators to 
ensure that forms were adequately and fully completed. The records are kept by 
the investigator to ensure confidentiality.  
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 All questionnaires were reviewed by the investigator and the team, to ensure that 
they were accurate and complete. Data was entered onto a computerized 
database, and preparation of this and the data files for analysis was conducted 
by the investigator and the team.  
 
The data generated in this study belongs to investigators and the Powerbelt 
Steering Committee.  
 
2.4 Statistical considerations 
 
2.4.1 Sample size 
 
All available data from the original survey was used in this survey. 690 study 
participants (399 female and 291 male) in Embalenhle were sampled for the 
survey; and 155 study participants (76 female and 79 male) sampled in Dunusa. 
There is a difference in the sample sizes in the two sites and this may be 
attributed to the fact that there was a smaller population at the Dunusa clinics, as 
well as budgetary constraints of the project.  
 
2.4.2 Analysis 
 
Analysis was conducted using STATA version 8. 
 
2.4.3 Descriptive analysis 
 
1. Descriptive frequencies of the distribution of HIV, sex, age, STI, any STI 
and site 
2. Students t-test for significant difference in mean age of males and females 
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 3. Chi square tests for associations between HIV status and categorical 
variables (such as sex, individual STIs, any STI and site). In the case of 
ordinal explanatory variables (such as agegroup) a chi square test for 
trend was used. 
a. We created a variable ‘Any STI’ and determined the 
seroprevalence for participants having any STI in both 
communities. 
4. By means of inferential statistics, confidence intervals were used to show 
precision with which prevalences are estimated in different sub-groups. 
Confidence intervals were also used for odds ratios. The process for 
calculating this interval is complicated as this ratio is not normally 
distributed. The interval contains the value of the true odds ratio with 95% 
confidence. If the odds are the same in each group of comparison, then 
the value of the odds ratio is approximately 1. If the confidence interval for 
the odds ratio does not contain 1, then there is strong evidence of 
association between exposure and the risk of infection, while if the 
confidence interval contains 1, then we have insufficient evidence to 
conclude that there is an association.  
 
2.4.4 Analysis methods for logistic regression models 
 
1. Logistic regression models were fitted. 
2. Factors investigated were age, sex, site and STI presence, as well as 
pairwise interactions between these factors.   
3. Model selection was conducted using Likelihood-Ratio tests.  
4. Model interpretation: In order to interpret interactions (effect modification), 
we adjusted for variables in the model and observe predicted probabilities. 
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 2.4.4.1 Maximum likelihood estimation (20, 21) 
 
In linear regression, the method of least squares is used to estimate regression 
coefficients, i.e. we choose those estimates of α and β that minimize the sum of 
squared residuals (20, 21). This approach does not work well in logistic 
regression, or for the entire family of generalized linear models. Instead we use 
another approach called maximum likelihood estimation (20, 21).  
 
The maximum likelihood estimate of π is the value of π that assigns the greatest 
probability to the observed outcome (20, 21). In general, maximum likelihood 
estimates do not have simple closed solutions but must be found iteratively using 
numerical methods (20, 21).  
 
A likelihood function looks deceptively like a probability density function. It is 
important to realize that they are different (20, 21). A probability density function 
uses fixed values of the model parameters and indicates the probability of 
different outcomes under this model (20, 21). A likelihood function holds the 
observed values fixed and shows the probability of this outcome for the different 
possible values of the parameters (20, 21).  
 
We discuss how the likelihood approach can be used to provide a general means 
of hypothesis testing. A hypothesis test is based on calculating a test statistic and 
its corresponding P-value (also known as the significance level), in order to 
assess the strength of the evidence against the null hypothesis (of no association 
between exposure and outcome in the population) the smaller the P Value, the 
stronger the evidence against the null hypothesis (22).  
 
There are 3 different types of tests based on the log likelihood: 
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 1. The Likelihood Ratio test, based on the value of the log likelihood ratio at 
the null value of the parameter (22). 
2. The Wald test uses the value of the fitted quadratic approximation to the 
log likelihood ratio at the null, rather than the actual value of the log 
likelihood ratio at this point (22). 
3. The Score test, based on fitting an alternative quadratic approximation to 
the log likelihood ratio which has the same gradient and curvature at the 
null value of the parameter, rather than at the maximum likelihood 
estimation (22). 
 
2.4.4.2 Choice of test for this project      (20, 21, 22)  
 
Likelihood ratio test in regression models 
 
Hypothesis testing in regression models can be carried out using either Wald 
tests or likelihood ratio tests (22). Likelihood ratio tests tend to be favoured for all 
but the simplest of cases, for the following reasons: 
 
1. the lack of dependence of the likelihood ratio statistic on the scale used for 
the parameter(s) of interest 
2. the ease with which the calculation and interpretation of likelihood ratio 
statistics can be carried out in a more complex situations 
3. In contrast, although the Wald tests are directly interpretable for exposure 
variables which are represented by a single parameter in the regression 
model, they are less useful for a categorical variable which is represented 
by a series of indicator variables in the regression model 
 
The likelihood ratio test described above for a single exposure is a special case 
of a more general likelihood ratio test that applies to more complex situations 
involving several model parameters (22). An example is in the regression 
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 modelling where we have estimated the effect of a categorical exposure variable 
using k indicator variables and wish to test the null hypothesis that the exposure 
has no association with the outcome. In such situations we wish to test the joint 
null hypothesis that k parameters equal their null values. The likelihood ratio test 
is based on comparing the log likelihoods obtained from fitting the following 2 
models: 
 
1. Lexc, the log likelihood of the model excluding the parameters to be tested 
2. Linc, the log likelihood of the model including the parameters to be tested  
 
Then the likelihood ratio statistic (LRS) has a χ2 distribution with degrees of 
freedom equal to the number of parameters omitted from the model (22).  
 
The three tests above generalize to more complicated situations. Given a 
sufficiently large sample size, all of these methods are equivalent (20, 21). 
However likelihood ratio tests and score tests are more accurate than the Wald 
test for most problems encountered in practice. The likelihood and score tests 
are used in practice for this reason (20, 21).  
 
The likelihood ratio test has the property that is unaffected by transformations of 
the parameter of interest and is preferred over the score test for this reason.  
The Wald test is much easier to calculate than the other two, which are often not 
given by statistical software packages. It is common practice to use the Wald test 
when it is the only one that can be easily calculated.  
 
Wide divergence between these three tests can result when the log likelihood 
function is poorly approximated by a quadratic curve. In this case, it is desirable 
to transform the parameter in such a way as to give the log likelihood function a 
more quadratic shape.  
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 When interpreting the effects of factors in the presence of interactions, we have 
to remember (a) that odds ratios are multiplicative rather than additive and (b) a 
constant factor change in the odds does not correspond to a constant change or 
a constant factor change in the probability. For this reason interpretations based 
on predicted probabilities are especially useful in jointly examining the effect of 
two categorical explanatory variables (holding other variables in the model 
constant) by means of a table of predicted probabilities (23).  
 
For the proposed set of data analyses, we made use of the likelihood ratio test 
and investigated changes in deviance as a means of selecting a best model for 
our data. Deviance is defined as a quality of fit statistic for a model (similar to R-
squared for ordinary least squares) that is often used for statistics hypothesis 
testing. The expression of deviance is simply – 2 times the log likelihood of the 
model of fit. While the deviance has a derivable asymptotic distribution under the 
assumption of the correctness of the model, it is rarely used. Instead the 
deviance is used to compare 2 models in particular of generalized linear models 
where it has a similar role to residual variance from analysis of variance in linear 
models. Suppose in the framework of the generalized linear model, we have two 
nested models, M1 and M2. In particular, suppose that M1 contains all of the 
parameters in M2, and k additional parameters. Then, under the null hypothesis 
that M2 is the true model, the difference between the deviances for the two 
models follows an approximate chi-squared distribution with k-degrees of 
freedom. 
 
2.5 Ethical considerations for the original baseline survey 
 
The committee for ethical clearance of the University of the Witwatersrand 
approved standard subject information sheets (reference No. 001109), that were 
translated into English, Sotho and Zulu and distributed in the community and 
clinics. The study did not make use of formal written informed consent as HIV 
testing was unlinked and anonymous.  
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 A protocol for feedback of STI results to the relevant clinic authorities and 
community notification was set up. It was agreed by clinics and hospitals of 
Evander Hospital in Embalenhle that health authorities would provide treatment 
for participants testing positive for sexually transmitted infections. Urine was 
collected for the detection of sexually transmitted infections N. gonorrhoeae and 
Chlamydia trachomatis by polymerase chain reaction. All urine specimens were 
bar-coded. Patients were given a copy of bar codes if they decided to return for 
results and treatment. Urine specimens were collected and transported by 
Contract Laboratory Services daily to Johannesburg.  
 
Men and Women were given health education about STIs including HIV 
prevention messages at each visit so that they had an understanding of the 
following: 
 
• transmission, 
• symptoms and signs, 
• impact on their health, their partner’s health and their children’s health, 
• treatment and how to access it, and 
• how to protect themselves, their sexual partners and their children from 
future infections 
• HIV/STI counselling 
 
Participants were informed about the purpose of the study, the commitment of 
time, and their saliva specimen collection for HIV testing. They were informed 
that these procedures were undertaken throughout the study to ensure that 
volunteers clearly understood that there may be reasons for ineligibility to 
participate in the study. They were told that they were free to withdraw at any 
time with no jeopardy to their medical care with respect to treatment of STI 
infection. They were told that screening for sexually transmitted infections other 
than HIV would also be performed during the study and that this would be done 
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 by collection of urine specimens. They were advised to discuss the study with 
their regular sexual partner but the consent of their partner would not be 
essential. Written informed consent was not administered by the study staff at 
screening and enrolment. 
 
Participants were counselled about the importance of condom use at the study 
visit and this was an active procedure undertaken by an experienced 
counsellor. Hypo-allergenic non-spermicidal lubricated condoms were given to 
the participants. 
 
HIV testing was unlinked and anonymous. Participants were offered the option of 
whether to participate or not in the prevalence study but they were not to receive 
their HIV results.  
 
HIV testing was conducted using the ORASURE Saliva test kit. Age and sex 
were the only information collected with the specimens. No personal identifiers 
were collected. Specimens were stored and transported by Contract Laboratory 
Services daily to Johannesburg. There was no HIV pre- and post-test counselling 
offered. Participants were not given the option of receiving their HIV test results.  
 
2.5.1 Confidentiality, ethics and responsibilities of the investigators 
 
Full medical and social confidentiality is maintained with all data records. No 
names were displayed on any form of report or publication and interview 
assessment forms were kept by the investigator of the study to ensure 
confidentiality.  
The investigators were responsible for obtaining ethical approval for the study 
(ethical clearance was obtained by the HIV Management Solution, Wits Health 
Consortium). The investigators were responsible for the implementation and 
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 optimization of the standard operating procedures to be used in the semi-
structured interviews.  
 
The investigators, based at the CSIR, were responsible for the reports of the 
progress of the study and financial reports. 
 
The study was conducted according to ICH-GCP guidelines and the current 
version of the Declaration of Helsinki (South Africa 1996.). It was the 
responsibility of the local investigators to abide by this. 
 
2.5.2 Ethical considerations 
 
The study made use of secondary data analysis from an original study, which 
attained ethical clearance from the Committee for Ethical Clearance, University 
of the Witwatersrand.
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 3. Results 
 
Six hundred and ninety participants from Embalenhle and 155 participants from 
Dunusa were included in the analysis. The sex distribution for Embalenhle was 
399 females and 291 males, and for Dunusa 76 females and 79 males. There 
was a significant difference between the distribution of sex across sites (p=0.04),  
table 2.  
 
Embalenhle Dunusa P Value
n % n %
Sex 0.04*
Male 291 42.17 79 50.97  
Female 399 57.83 76 49.03  
Agegroup (yrs) 0.37*
17-24 192 27.83 37 23.87  
25-34 255 36.96 69 44.52  
35-44 192 27.83 38 24.52  
45-50 51 7.39 11 7.10  
STI Prevalence
HIV 0.75*
Pos 231 33.48 54 34.84  
Neg 459 66.52 101 65.16  
N. gonorrhoeae 0.23*
Pos 29 4.35 10 6.67  
Neg 638 95.65 140 93.33  
C. trachomatis 0.22*
Pos 48 7.25 15 10.27  
Neg 614 92.75 131 89.73  
Any STI 0.28*
Pos 70 10.57 20 13.7  
Neg 592 89.43 126 86.3
*Chi-square test
Table 2. Descriptive statistics for male and female study participants by site in an HIV
sero-prevalence study in Mpumalanga in 2003
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 There also seemed to be a symmetrical distribution of sex by agegroup with 
majority of the male participants presenting between the ages 25 and 34 years 
with females showing a similar pattern with majority of the women presenting 
also between the ages 25 and 35 years. The mean age for males at Embalenhle 
was 31.75 years (95% CI, 30.73; 32.70) and 31.34 years in Dunusa (95% CI, 
30.73; 32.70), p=0.39. The mean age for females at Embalenhle was 31.01 years 
(95% CI, 30.17; 31.84) and 31.89 years in Dunusa (95% CI, 30.19; 33.59), 
p=0.71.  
 
Table 2 also describes the prevalence of STIs across sites as follows: HIV 
seroprevalence in Embalenhle was 33.48% (95% CI, 29.96; 37.13) and 34.84% 
(95% CI, 27.37; 42.89) in Dunusa, p=0.75. N. gonorrhoea seroprevalence in 
Embalenhle was 4.45% (95% CI, 2.93; 6.18) and 6.67% in Dunusa (95% CI, 
3.24; 11.92), p=0.23. C. trachomatis seroprevalence in Embalenhle was 7.25% 
(95% CI, 5.39; 9.49) and 10.27% in Dunusa (95% CI, 5.87; 16.39), p=0.22.  
The seroprevalence of having any STI in Embalenhle was 10.57% (95% CI, 8.33; 
13.17) and 13.7% in Dunusa (95% CI, 8.57; 20.36), p=0.28. 
 
Table 3a describes the distribution of independent variables by sex and the 
seroprevalence of STIs by sex as follows: HIV seroprevalence in males was 
28.65% (95% CI, 24.09; 33.55) and 37.68% in females (95% CI, 33.31; 42.21), 
p=0.006. N. gonorrhoeae seroprevalence in males was 3.88% (95% CI, 2.14; 
6.42) and 5.48% (95% CI, 3.58; 7.99) in females, p=0.29. C. trachomatis 
seroprevalence in males was 8.15% (95% CI, 5.52; 11.49) and 7.52% in females 
(95% CI, 5.27; 10.35), p=0.75. The seroprevalence for having any STI in males 
was 10.39% (95% CI, 7.03; 14.04) and 11.73% in females (95% CI, 8.91; 15.06), 
p=0.55. 
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 Male Female P Value
n % n %
Site 0.04*
Embalenhle 291 78.65 399 84  
Dunusa 79 21.35 76 16  
Agegroup (yrs) 0.53*
17-24 104 28.11 125 26.32  
25-34 133 35.95 191 40.21  
35-44 102 27.57 128 26.95  
45-50 31 8.38 31 6.53  
STI Prevalence
HIV 0.006*
Neg 264 71.35 296 62.32  
Pos 106 28.65 179 37.68  
N. gonorrhoeae 0.29*
Neg 347 96.12 431 94.52  
Pos 14 3.88 25 5.48  
C. trachomatis 0.74*
Neg 327 91.85 418 92.48  
Pos 29 8.15 34 7.52  
Any STI 0.55*
Neg 319 89.61 399 88.27  
Pos 37 10.39 53 11.73  
*Chi-square test
Table 3a. Descriptive statistics for participants by sex in an HIV
sero-prevalence study in Mpumalanga in 2003
 
 
 
Males Females
n=291 n=399
Embalenhle Mean 95% CI Mean 95% CI Mean 95% CI P Value
Age 31.32 30.67; 31.97 31.75 30.73; 32.77 31 30.17; 31.84 0.26
Males Females
n=79 n=76
Dunusa Mean 95% CI Mean 95% CI Mean 95% CI P Value
Age 31.61 30.35; 32.88 31.34 29.44; 33.24 31.89 30.19; 33.59 0.67
Table 3b. Distribution of Age by Site and Sex
*Two-sample test with equal variances  
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 n % n % Unadjusted OR 95% CI P Value
Site
Embalenhle 231 33.48 459 66.52 1 reference  
Dunusa 54 34.84 101 65.16 1.06 0.73-1.53 0.75*
Sex
Male 106 28.65 264 71.35 1 reference  
Female 179 37.68 296 62.32 1.51 1.12-2.01 0.006*
Agegroup (yrs)  
17-24 74 32.31 155 67.69 1 reference  
25-34 135 41.67 189 58.33 1.5 1.05-2.13 0.03*
35-44 62 26.96 168 73.04 0.77 0.52-1.56 0.21*
45-50 14 22.58 48 77.42 0.61 0.32-1.18 0.14*
STI Prevalence
N. gonorrhoeae
Neg 255 32.78 523 67.22 1 reference  
Pos 19 48.72 20 51.28 1.95 1.01-3.72 0.04*
C. trachomatis
Neg 241 32.35 504 67.65 1 reference
Pos 30 47.62 33 52.38 1.9 1.13-3.19 0.02*
Any STI
Neg 231 32.17 487 67.83 1 reference
Pos 41 45.56 49 54.44 1.76 1.12-2.75* 0.01
*Chi-square test
Table 4. Comparison between male and female study participants by HIV serostatus in 
HIV Pos HIV Neg
an HIV sero-prevalence study in Mpumalanga in 2003
 
 
Table 4 describes the distribution of independent variables by HIV sero-status.  
There was no evidence that HIV prevalence differed across sites {(OR = 1.06, 
95% CI (0.73; 1.53 P=0.75)}.  HIV serostatus differed across agegroup with the 
highest prevalence in the agegroup 25-34 years, p=0.03. Participants presenting 
positive with N. gonorrhoeae were more likely to be HIV positive {OR=1.95, (95% 
CI, 1.01; 3.72, p=0.04)}, 1.95 times more likely to be HIV positive when 
presenting with C. trachomatis {(95% CI, 1.13; 3.19, p=0.02)} and 1.76 times 
more likely to be HIV positive when presenting with any STI {(95% CI, 1.12; 2.75, 
p=0.01)}.  
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Figure 3 Distribution of agegroup by sex 
 
Figure 3 illustrates the distribution of agegroup by sex with the majority of 
females presenting between the ages of 25 and 34 years and peaking in that 
same agegroup. The distribution of males was somewhat more uniform across 
age groups.  
 
27 
 
 28
39
27
7
28
35
29
8
0
5
10
15
20
25
30
35
40
45
17-24 25-34 35-44 45-50
Agegroup (10-year bands)
Pe
rc
en
ta
ge Females
Males
 
Figure 4 Distribution of agegroup by sex - Embalenhle 
 
Figure 4 illustrates the distribution of agegroup by sex in the Embalenhle site with 
the majority of the females presenting between the ages of 25 and 34 years and 
peaking in the same agegroup. The distribution of males is unimodal with a peak 
in the 25-34 year agegroup; the frequency of males in 35-44 year agegroup was 
higher than in the 17-24 year agegroup. 
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Figure 5 Distribution of agegroup by sex - Dunusa 
 
Figure 5 illustrates the distribution of age by sex in Dunusa and shows a similar 
pattern to Embalenhle for males and females. The peak for females is still in the 
25-34 year agegroup and the distribution for males is unimodal with a peak in the 
25-34 year agegroup. 
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 3.1 Model Selection 
 
The analysis for this study involved logistic regression modelling and model 
comparisons. For purposes of the analysis, we describe the output of 3 logistic 
regression models and the model comparisons as highlighted in section 2.4.4.  
All models used HIV as the dependant variable and we present predictors for HIV 
in the outputs. Table 5 describes the candidate models, logistic regression 
outputs including the variables and interactions used for model comparisons.  
 
Variables Model 1 (df) Model 2 (df) Model 3 (df) Model 4 (df) Model 5 (df) Model 6 (df)
Sex √ (1) (1) (1) (1) (1) (1)
Site (1) (1) (1) (1) (1) (1)
Agegroup            
18-24 √ √ √ √ √ √
25-34 √ (1) √ (1) √ (1) √ (1) √ (1) √ (1)
35-44 √ (1) √ (1) √ (1) √ (1) √ (1) √ (1)
45-50 √ (1) √ (1) √ (1) √ (1)
Chlamydia trachomatis √ (1) √ (1) √ (1)
Neisseria gonorrhoeae √ (1) √ (1) (1) √ (1)
Site*Sex √ (1) √ (1) √ (1) √ (1) √ (1) √ (1)
Sex*Agegroup √ (3) √ (3) √ (2) √ (2) √ (3) √ (3)
Sex*C.trachomatis √ (1)
Sex*N.gonorrhoeae √ (1) √ (1) √ (1)
Degrees of Freedom 13 12 10 7 9 10
Number of Observations 805 805 747 783 845 805
Exclusions
Log Likliehood -489.27644 -489.2805 -460.42456 -483.94022 -516.54848 -492.12893
Goodness of Fit (P Value) 0.67 0.71 0.73 0.84 0.79 0.33
Table 5. List of All Candidate Models
Missing values include STIs, Chlamydia trachomatis and Neisseria gonorrhoeae
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 For the model comparison, we made use of the likelihood ratio test and 
investigated changes in deviance as a means of selecting a best model for our 
data. Please refer to 2.4.4.5 for model justification.  
 
Model 1 Model 2 Difference in deviance
Chi2 - 2[-Log LiklihoodM2-(-Log Liklihood M1)]
Number of observations 805 805
LR Chi2 48.53 48.52
df 13 12
Prob > Chi2 <0.001 <0.001
Pseudo R2 0.05 0.05
Log Liklihood -489.2764 -489.281 0.00812
Model 1 Model 2
Number of observations 805 805
Number of covariate patterns 50 50
Pearson Chi2 31.79 31.81
Prob > Chi2 0.67 0.71
Assumption
LR Chi2 0.01
df 1
Prob > Chi2 0.92
Table 6. Comparison of Model 1 and 2
Model 2 is nested in Model 1
Logistic Model for HIV, goodness of fit test
Liklihood ratio test
 
 
Table 6 illustrates the comparison of model 1 and 2. The change in deviance 
between model and 1 and 2 is 0.00812 on 1 d.f. Thus there is no evidence 
(p=0.92)  that model 1 gives a better explanation of the data than model 2, so we 
can keep model 2 and do not need to use the more complex model 1. We can 
also note that there is no evidence of a lack of fit for either model.  
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 Model 3 Model 4 Difference in deviance
Chi2 - 2[-Log LiklihoodM4-(-Log Liklihood M3)]
Number of observations 747 747
LR Chi2 40.81 35.95
df 10 7
Prob > Chi2 <0.001 <0.001
Pseudo R2 0.04 0.04
Log Liklihood -460.4246 -462.855 4.8603
Model 3 Model 4
Number of observations 747 747
Number of covariate patterns 42 12
Pearson Chi2 25.73 1.32
Prob > Chi2 0.73 0.86
Assumption
LR Chi2 4.86
df 3
Prob > Chi2 0.18
Table 7. Comparison of Model 3 and 4
Logistic Model for HIV, goodness of fit test
Liklihood ratio test
Model 4 is nested in Model 3
 
 
Table 7 illustrates the comparison of model 3 and 4. The change in deviance 
between model and 3 and 4 was 4.8603 with 3 d.f. Thus there is no evidence 
(p=0.18) that model 3 gives a better explanation of the data than model 4, thus 
model 3 does not give an improvement over model 4, so we prefer the simpler 
model 4.  
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 Model 2 Model 6 Difference in deviance
Chi2 - 2[-Log LiklihoodM6-(-Log Liklihood M2)]
Number of observations 805 805
LR Chi2 48.52 42.82
df 12 10
Prob > Chi2 <0.001 <0.001
Pseudo R2 0.05 0.04
Log Liklihood -489.2805 -492.1289 5.69686
Model 2 Model 6
Number of observations 805 805
Number of covariate patterns 50 29
Pearson Chi2 31.81 20.05
Prob > Chi2 0.71 0.33
Assumption
LR Chi2 5.7
df 2
Prob > Chi2 0.06
Table 8 Comparison of Model 2 and 6
Logistic Model for HIV, goodness of fit test
Liklihood ratio test
Model 6 is nested in Model 2
  
 
Table 8 illustrates the comparison of model 2 and 6. The change in deviance 
between model and 2 and 6 was 5.69686; after conducting the likelihood ratio 
test, prob > chi2 = 0.06 (3df). There is some evidence that model 2 is superior to 
model 6 (p=0.06); so we will interpret model 2 as it may give a richer 
interpretation than model 6.  
 
We present parameter estimates for the models chosen above although we 
made further comparisons between models with the same observations but this 
is not presented. No comparison was made between model 6 and 3 or model 6 
and 4 due to differing number of observations. Model 6 and model 4 and model 2 
were therefore chosen as the ‘best’ models to fit the data. We also note that 
there are missing values in certain variables which results in three models, as we 
cannot compare these three models. One of the difficulties was the patterns of 
the missing data which could have been addressed using imputation methods 
however this was beyond of the scope of the analysis methodology of the 
assignment.  
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 Factors Odds Ratio P Value 95% CI
Sex
Male 1 reference  
Female 3.22 <0.001 1.68-6.19
Site
Embalenhle 1 reference  
Dunusa 0.69 0.239 0.38-1.28
Agegroup (yrs)
18-24 1 reference  
25-34 2.59 0.003 1.37-4.87
35-44 2.14 0.03 1.09-4.23
45-50 1.38 0.53 0.50-3.80
STI
Neisseria gonorrhoeae
Neg 1 reference  
Pos 3.18 0.04 1.03-9.93
Chlamydia trachomatis
Neg 1 reference  
Pos 1.59 0.1 0.91-2.78
Sex by agegroup interactions
Female (25-34) 0.41 0.03 0.18-0.90
Female (35-44) 0.2 <0.001 0.08-0.47
Female (45-50) 0.26 0.06 0.06-1.04
Site by sex interactions
Females (Dunusa) 2.31 0.04 1.03-5.19
Neisseria gonorrhoeae 
by sex interactions
Males (NG Positive) 0.32 0.108 0.08-1.29
Table 9a. Results of Logistic Regression Model 2
 
 
Table 9a describes the output of the regression estimates for model 2. Further 
interpretations of interactions involving effects are based on the table of predicted 
probabilities (tables 9b, 9c and 9d).  
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Model 2 Male 95% CI Female 95% CI
Community 29.73 24.49; 35.56 34.65 29.88; 39.74
Clinic 21.59 13.71; 32.32 46 34.35; 58.11
Table 9b. Adjusting by Agegroup and STIs to determine the predicted 
 probability of HIV by Site and Sex
 
 
In table 9b we can see a strong sex by site interaction; in the community, the 
difference in HIV prevalence between females and males is much smaller than 
the difference in the clinic.  
 
Agegroup Male 95% CI Female 95% CI
(yrs)
18-24 17.29 11.04; 26.02 43.68 34.83; 52.95
25-34 34.89 27.15; 43.52 44.89 37.76; 52.25
35-44 31.43 22.87; 41.48 24.58 17.72; 33.02
45-50 22.85 11.02; 41.46 21.49 10.00; 40.29
Table 9c. Adjusting by Site and STIs to determine the predicted 
 probability of HIV by Agegroup and Sex - Model 2
 
 
We observe a strong sex by age interaction (table 9c), which is consistent with 
previous findings. For females, the prevalence is already high in the 18-24 year 
old group, and then declines with increasing age. For males, the prevalence is 
lowest in the 18-24 old group, then peaks in the 25-34 year old group, remaining 
high in the 35-44 year group before declining in the 45-50 year old group. 
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 Model 2 Male 95% CI Female 95% CI
N. Gonorrhoeae
Neg 26.69 22.13; 31.82 36.7 32.08; 41.58
Pos 51.96 26.50; 76.44 36.85 20.12; 57.48
Table 9d. Predicted probability of HIV by N. Gonorrhoeae and Sex
 
Table 9d shows a strong sex by N. Gonorrhoeae interaction. The difference in 
HIV prevalence between males and females for having N. Gonorrhoeae is high 
and the odds are 3.18 (p=0.04) (table 9a). Males had a higher prevalence than 
females for N. Gonorrhoeae positives, while for N. Gonorrhoeae negatives, 
males has a lower HIV prevalence than females.     
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 Factors Odds Ratio P Value 95% CI
Sex
Male 1 reference  
Female 3.06 0.001 1.61-5.80
Site
Embalenhle 1 reference  
Dunusa 0.66 0.2 0.35-1.24
Agegroup (yrs)
18-24 1 reference  
25-34 2.56 0.003 1.37-4.79
35-44 2.02 0.04 1.03-3.94
45-50 1.45 0.47 0.54-3.91
Sex and agegroup interactions
Female (25-34) 0.39 0.02 0.18-0.87
Female (35-44) 0.2 <0.001 0.08-0.48
Female (45-50) 0.23 0.04 0.05-0.92
Site and sex interactions
Females (Dunusa) 2.36 0.04 1.03-5.41
Table 10a. Results of Logistic Regression Model 4
  
 
Table 10a describes the output of the regression estimates for model 4. All the 
main effects in the model, namely sex, site and agegroup, are also involved in 
interactions, so the interpretation of results from model 4 is based on the table of 
predicted probabilities. 
 
Model 4 Male 95% CI Female 95% CI
Community 29.46 24.04; 35.52 36.75 31.77; 42.02
Clinic 21.59 13.43; 32.83 44.82 33.03; 57.20
Table 10b. Adjusting by Agegroup and STIs to determine the predicted 
 probability of HIV by Site and Sex
 
 
In table 10b we see a strong sex by age interaction, with females more likely to 
be HIV positive than males in the community, the difference in HIV prevalence 
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 between females and males is much smaller than the difference in the clinic. The 
findings are similar to model 2.  
 
Agegroup Male 95% CI Female 95% CI
(yrs)
18-24 18.23 11.79;27.10 42.86 34.14;52.02
25-34 36.35 28.51;44.98 44.96 37.84;52.29
35-44 30.99 22.53;40.92 24.13 17.39;32.46
45-50 18.22 11.79;27.10 43.21 34.49;52.37
Table 10c. Adjusting by Site and STIs to determine the predicted 
 probability of HIV by Agegroup and Sex - Model 4
 
 
There is a strong sex by age interaction in table 10c, which is consistent with 
previous findings (model 2). For females, the prevalence is already high in the 
18-24 year old group, and then declines with increasing age. For males, the 
prevalence is lowest in the 18-24 old age group, and then peaks in the 25-34 
year old group, drops in the 35-44 year group before declining rapidly in the 45-
50 year old age group.
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 Factors Odds Ratio P Value 95% CI
Sex
Male 1 reference  
Female 3.04 0.001 1.60-5.78
Site
Embalenhle 1 reference  
Dunusa 0.7 0.25 0.39-1.28
Agegroup (yrs)
18-24 1 reference  
25-34 2.56 0.003 1.37-4.87
35-44 2.05 0.04 1.09-4.23
45-50 1.42 0.49 0.50-3.80
STI
GPCR
Neg 1 reference  
Pos 1.73 0.11 0.88-3.40
Sex and agegroup interactions
Female (25-34) 0.4 0.02 0.18-0.88
Female (35-44) 0.19 <0.001 0.08-0.47
Female (45-50) 0.24 0.04 0.06-0.95
Site and sex interactions
Females (Dunusa) 2.3 0.04 1.03-5.11
Table 11a. Results of Logistic Regression Model 6
  
 
Table 11a describes the output of the regression estimates for model 6. 
Participants with N. Gonorrhoeae were 1.73 times more likely to be HIV positive, 
{(95% CI, 0.88; 3.40 p=0.11)}. This effect is not significant however shows that 
those infected with N. Gonorrhoeae are at an increased risk of HIV. Further 
interpretations of interactions are based on the table of predicted probabilities 
(tables 11b and 11c). 
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Model 6 Male 95% CI Female 95% CI
Community 29.88 24.69; 35.64 34.91 30.15; 39.99
Clinic 23 14.83; 33.89 44.09 32.64; 56.19
Table 11b. Adjusting by Agegroup and STIs to determine the predicted 
 probability of HIV by Site and Sex
 
 
In table 11b we see a strong sex by site interaction; in the community, the 
difference in HIV prevalence between females and males is much smaller than 
the difference in the clinic. The findings are similar to model 2 and 4.  
 
Agegroup Male 95% CI Female 95% CI
(yrs)
18-24 18.22 11.78; 27.11 42.59 33.88; 51.79
25-34 36.29 28.45; 44.93 44.74 37.61; 52.09
35-44 31.35 22.85; 41.33 24 17.27; 32.36
45-50 24.08 11.88; 42.72 20.38 9.41; 38.68
Table 11c. Adjusting by Site and STIs to determine the predicted 
 probability of HIV by Agegroup and Sex - Model 6
 
 
There is also a strong sex by age interaction in table 8c, which is consistent with 
previous findings (model 2 and 4). For females, the prevalence is already high in 
the 18-24 year old group, and then declines with increasing age. For males, the 
prevalence is lowest in the 18-24 old age group, then peaks in the 25-34 year old 
age group, drops in the 35-44 year group before declining rapidly in the 45-50 
year old group. 
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 4. Discussion 
 
The study is consistent with the fact that HIV is a public health challenge in South 
Africa. HIV seroprevalence among study participants was high with a crude study 
seroprevalence of 33.72% (95% CI 30.54; 37.02).  
 
Community STI seroprevalence was high, 11.14% (95% CI 9.05; 13.51); with  
N. gonorrhoeae being at 4.77% (95% CI 3.41; 6.47) and C. trachomatis being at 
7.79% (95% CI 6.04; 9.87), with no significant difference between males and 
females.  
 
Having any STI was a risk factor for HIV {unadjusted OR=1.76, (95% CI, 1.12; 
2.75, p=0.01)}. Females were at higher risk of acquiring HIV than males 
{OR=1.51, (95% CI, 1.12; 2.01, p=0.006). Both N. gonorrhoeae and  
C. trachomatis were risk factors for HIV infection (results not shown). 
 
The distribution of agegroup by sex showed the majority of females in the study 
were between the ages of 21 and 35 years and peaking in the 21-25 year 
agegroup. The distribution of males was somewhat more uniform across the 
agegroups and the distribution was bimodal when stratified by site.  
 
The findings of the regression estimates and predicted probabilities together with 
the descriptive statistics suggest that the distribution of HIV in this setting is 
complex as shown by the predicted probabilities from the three selected logistic 
regression models.  
 
All models gave similar predicted HIV seroprevalences in the two-way 
breakdown by site and sex, as described in the results,  
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 We notice from the predicted probability output that HIV seroprevalence for 
females is 34.65% and 29.73% for males at the community level, table 9b, model 
2.  The difference between female and male was 4.92% whilst the difference in 
HIV seroprevalence between sexes at the clinic level was 24.41% for the same 
model. Similar findings are noted in model 4. Thus the degree of difference in 
HIV prevalence between sexes differs significantly between the two sites; this is 
interesting and shows that the comparison of seroprevalence between males and 
females might differ in different settings, thus further investigation into this is 
required. 
This distribution of HIV across age strata from the predicted probability output is 
more consistent with the current epidemiology of HIV in South Africa (10, 15).   
 
The effect of sex differed for site; for females the HIV seroprevalence was higher 
in the health care facility, while for males the HIV prevalence was higher in the 
community. This is interesting and may be explained or accounted for by the 
different health seeking profiles of males and females.  
 
Nicolosi et al. compared the efficiency of male to female and female to male 
sexual transmission of HIV (24). Using a logistic regression analysis and 
controlling for multiple confounders, it was found that the efficiency of male to 
female transmission was 2.3 times greater than female to male transmission. It is 
suggested that between gender differences in the contact surfaces and intensity 
of exposure during sexual intercourse are possible reasons for the gender 
differential.  
 
Gregson et. al report that substantial age differentials between female and male 
sexual partners in Manicaland are the major behavioural determinant of the more 
rapid rise in HIV prevalence in young women than in men (25). After controlling 
for confounders, it was demonstrated that a large gender effect remains after 
controlling for confounders {OR = 6.04 ((95% CI. 1.49; 24.47)}.  
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 Glynn et. al. suggest that behavioural factors could not fully explain the 
discrepancy in HIV prevalence between males and females (26). Despite the 
tendency for women to have older partners, young men were at least as likely to 
encounter an HIV infected partner as young women. It is likely that the greater 
susceptibility of women to HIV infection is an important factor both in explaining 
the male to female discrepancy in HIV prevalence and in driving the epidemic.  
 
The results of this study could point to gender specific health seeking behaviour 
patterns not only for HIV but for general clinic disease showing us, as 
documented in other studies, that females have different health seeking 
behaviour patterns than males (11, 16). 
 
4.1 Study Limitations 
 
The sampling frame of the initial study was not available for the purposes of 
reporting and informing the secondary analysis of this study. The initial design of 
the seroprevalence survey was not made available and thus the participant 
response rates are not known. We are therefore unable to quantify the non-
response rates or mention the bias in sampling. The availability of this 
information would better inform us of the nature of the health seeking behaviour 
pattern of the population under investigation. Also we must take into account the 
unequal distribution of the sample between sites; the secondary analysis is not 
able to comment on the methodology of the initial design.  
 
Furthermore, the secondary analysis included only disease prevalence and 3 
demographic variables into the descriptive and regression models, as these were 
the only variables made available to us. The lack of socio-demographic variables 
proves to be a serious limitation in the analysis as this would have been better 
able to inform us about other risk factors in this community during the period of 
the study.  
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 Due to the fact that the binary regression models are nonlinear, no single 
approach to interpretation can fully describe the relationship between a variable 
and the outcome. In general, the estimated parameters from the binary 
regression model do not provide useful information for understanding the 
relationship between independent variables and the outcome. With the exception 
of the rarely used method of interpreting the latent variable, substantive 
meaningful interpretations are based in the predicted probabilities and functions 
of those probabilities (23). 
 
It is also clear from this study that it may not be appropriate to compare HIV 
prevalence from hospital based studies and community studies as huge site and 
sex as well as site and age group interactions are often encountered in addition 
to being documented in the secondary analysis of this assignment. The analysis 
would have been more manageable if analysis was analysed separately by site 
resulting in fewer levels of interaction to manage however the study highlights 
crucially the difficulty of combining data from the 2 sites.  
 
Also note that this was a cross sectional study; no mention of clustering was 
made available and could have impacted differently on the analysis. Cross 
sectional studies often deal with exposures that cannot change; for such 
exposures current information such as in this study is useful however for variable 
exposure, current information is less desirable (27). Fortunately this was not the 
case in this study. This study had no etiological objectives and no reference to 
cause of the primary outcome of disease was made.  
 
We should not use this study to make generalizations on the nature and spread 
of the HIV epidemic nationally or even in Mpumalanga province, as the initial 
study was designed to measure the burden of disease in a mining community, of 
which the population may be at a higher risk for contraction of infectious disease. 
The risk profile of this community differs considerably from the general population 
however we must take into account that studies like this are required on a larger 
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 National Scale in order to ascertain risk profiles of communities so that 
interventions to limit the spread of HIV or manage the care of HIV infected 
patients can be better planned.  
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 5. Conclusion and Recommendation  
 
This study informs us that there is a need for more information than what is 
provided by the National Antenatal survey. With the advent of community surveys 
such as the Nelson Mandela HSRC study, we will be able to better understand 
the epidemic at the community level. At the current stage of this epidemic, 
community studies will be better able to inform public health professionals on 
strategies for planning and operationalizing the current comprehensive care 
management and treatment program.  
 
Differences in the spread of HIV in the male and female population can be 
accounted for by a complex interplay of sexual behaviour and biological factors 
that affect the probability of HIV transmission per sex act (28). Sexual behaviour 
patterns are determined by cultural and socioeconomic contexts and in sub-
Saharan Africa, some traditions and socioeconomic developments have 
contributed to the extensive spread of HIV infection (28). Resulting from this 
spread of HIV, we are faced with challenges in quantifying differential infection 
rates in population groups thus making planning for targeted interventions 
difficult. The subordinate position of women, impoverishment and decline of 
social services, rapid urbanization and modernization are factors that contribute 
to the evolutionary epidemiological profile and public health interventions are 
challenged to address this.  
 
The National Strategic Plan (29) clearly states that there is a need to scale up the 
management of HIV care and treatment programs in South Africa, therefore more 
studies focused on describing the epidemiology of HIV for populations at high 
and low risk is required. As gathered from this survey, the difference in the 
prevalence of HIV as seen from the predicted probabilities of HIV across males 
and females calls for further investigation on a broader scale and therefore we 
should be encouraging large community based surveys such as the HSRC 
survey to continue and better inform the management of the National 
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 Comprehensive Care Management and Treatment program (30).
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